Okan Gulel

Okan Gulel

Auto-generated profile, based on publicly available information

Okan Gulel

Department of Cardiology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2008 in Echocardiography
Verified
Journal Article
Closed access
PDF file
OGOkan Gulel
Okan Gulel
KSKorhan Soylu
Korhan Soylu
SYSerkan Yüksel
Serkan Yüksel
MKMuge Karaoglanoglu
Muge Karaoglanoglu
KCKuddusi Cengiz
Kuddusi Cengiz
NANurol Arik
Nurol Arik

25 December 2008 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
OGOkan Gulel
Okan Gulel
SYSerkan Yüksel
Serkan Yüksel
KSKorhan Soylu
Korhan Soylu
OKOzgur Kaplan
Ozgur Kaplan
OYOzcan Yilmaz
Ozcan Yilmaz
MSMahmut Sahin
Mahmut Sahin

14 December 2015 in Echocardiography
Verified
Journal Article
Closed access
PDF file
OGOkan Gulel
Okan Gulel
MAMurat Akcay
Murat Akcay
KSKorhan Soylu
Korhan Soylu
GAGokhan Aksan
Gokhan Aksan
SYSerkan Yuksel
Serkan Yuksel
MSMahmut Sahin
Mahmut Sahin

1 October 2005 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
OGOkan Gulel
Okan Gulel
TKTelat Keles
Telat Keles
HEHakan Eraslan
Hakan Eraslan
SASinan Aydogdu
Sinan Aydogdu
EDErdem Diker
Erdem Diker
VUVasfi Ulusoy
Vasfi Ulusoy
Radiographic contrast agents can cause acute decrease in renal functions. It is thought that anti-oxidant acetylcysteine can prevent contrast nephropathy. Fifty patients planned to undergo elective diagnostic coronary angiography with serum creatinine values above 1.3 mg/dL were included in the study. Acetylcysteine was given orally at a dose of 600 mg twice daily, on the day before and on the day of administration of contrast agent in the acetylcysteine group (n = 25). Acetylcysteine was not given to the control group (n = 25). Saline (0.9%) was given intravenously at a rate of 1 mL/kg/h for 12 hours before and 12 hours after administration of contrast agent. Contrast nephropathy was detected in 3 of 25 patients (12%) in the acetylcysteine group and 2 of 25 patients (8%) in the control group (P > 0.05). Contrast nephropathy was developed in 2 of 4 patients (50%) with baseline serum creatinine concentrations above 2.5 mg/dL, whereas it was developed in only 3 of 46 patients (6.5%) with baseline serum creatinine concentrations below 2.5 mg/dL (P = 0.04). It was detected that in patients planned to undergo elective diagnostic coronary angiography with renal dysfunction, oral acetylcysteine and hydration before the procedure was not more effective than hydration alone in the prevention of contrast nephropathy. High baseline serum creatinine values were detected as a risk factor for development of contrast nephropathy.

28 February 2007 in Echocardiography
Verified
Journal Article
Closed access
PDF file
OGOkan Gulel
Okan Gulel
KSKorhan Soylu
Korhan Soylu
MYMustafa Yazici
Mustafa Yazici
SDSabri Demircan
Sabri Demircan
KDKenan Durna
Kenan Durna
MSMahmut Sahin
Mahmut Sahin

1 January 2007 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
OGO. Gulel
O. Gulel
MEM. Elmali
M. Elmali
SDS. Demir
S. Demir
MTmustafa begenc tascanov
mustafa begenc tascanov